Report of Foreign Issuer (6-k)
05 8월 2014 - 5:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of
1934
For the
month of August 2014
Commission
File Number: 000-28508
Flamel Technologies, S.A.
(Translation
of registrant’s name into English)
Parc Club du Moulin à Vent
33 avenue du Dr. Georges Levy
69693 Vénissieux Cedex France
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): _______
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _______
Indicate by check mark whether registrant by furnishing the
information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under
the Securities Exchange Act of 1934.
If “Yes” is marked, indicate below the file number
assigned to the registrant in connection with Rule 12g3-2(b): 82-
In July 2014, Flamel Technologies issued the press releases
attached hereto as Exhibit 99.1 and incorporated herein by reference.
EXHIBIT LIST
Exhibit
Number
|
|
Description
|
99.1
|
|
Press release announcing Second Quarter of Fiscal Year 2014 Results
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: August 4, 2014
|
Flamel Technologies, S.A.
|
|
|
|
|
By:
|
/s/ Michael S. Anderson
|
|
|
Name: Michael S. Anderson
|
|
|
Title: Chief Executive Officer
|
EXHIBIT INDEX
Exhibit
Number
|
|
Description
|
99.1
|
|
Press release announcing Second Quarter of Fiscal Year 2014 Results
|
Avadel Pharmaceuticals (NASDAQ:AVDL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Avadel Pharmaceuticals (NASDAQ:AVDL)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024